Bristol Myers Squibb’s $10.8 million settlement in HIV drug antitrust case will get final approval, US judge says
Bristol Myers Squibb will get final approval of its antitrust settlement with a class of direct purchasers of HIV drugs, the California federal judge overseeing the litigation said today.Bristol Myers Squibb...To view the full article, register now.
Already a subscriber? Click here to view full article